Primary hyperhidrosis, a disorder in which people sweat significantly more than necessary for body cooling, “soaking clothing to dripping from hands,” such as the case for the study subject, can interfere profoundly with day-to-day life and lead to significant anxiety and low self-esteem. This new work is significant because it pinpoints the definitive, biological reason for at least a significant fraction of these patients: a defect in a nerve’s voltage-gated sodium channel rather than “nerves” in a psychological way.
Historically, hyperhidrosis has often been trivialised as a vanity concern or attributed to a person’s personality or nerves, meaning patients weren’t always treated seriously. Providing an actual genetic explanation for this underlying process also helps to remove stigma from the condition and pave the way for specific therapies beyond nerve cuts or gland-blocking medicines.
Sweating as a result of genetic alteration in hyperhidrosis
In this subset of patients, they suggest, the basic mechanism behind primary hyperhidrosis is a neurocutaneous channelopathy, a channel disease affecting ion channels of nerves that signal sweat glands. The principal molecule involved is a sodium channel, Nav1.8, a protein produced by the SCN10A gene, that normally contributes to electrical signalling between nerve cells in a precise fashion.
Basically, the research emphasises that for a subset of people with hyperhidrosis, this “gate” in the nerve cell membrane (Nav1.8) is wired in such a way by the genes that it tends to remain too open. This makes nerves that tell sweat glands what to do hyperactive constantly. This hyperactivity leads people with hyperhidrosis to have an exaggerated response to the normal emotions and stresses we all experience that, in most of us, result in minimal or subtle perspiration when the problem stems from a biological, not a mental, cause.
Experimental design
More than 180 primary hyperhidrosis patients were analysed for almost a decade by an international consortium, spearheaded by Frank Bosmans, an assistant professor of biological chemistry at the Johns Hopkins University School of Medicine, and including collaborators at Vrije Universiteit Brussel, Vrije Universiteit, the J. Craig Venter Institute, and Johns Hopkins. Within the inherited families of patients, they analysed the genes using whole-exome sequencing and searched for rare genetic variants concentrated in specific genes and found a significant enrichment in the gene family that encodes sodium channels called Nav. Within the Nav gene family, there was an especially high enrichment of mutations in a sodium channel called SCN10A (Nav1.8).
To assess whether these mutations lead to hyperhidrosis, the team created a knock-in mouse that expresses a Nav1.8 mutation (p.R14L) identified in the human population. Since rodents sweat only through their paws, they developed an assay that uses a microscopic iodinestarch mixture to count sweat droplets and quantify sweating in mutant versus wild-type mice. In addition, they used pharmacologic approaches, such as a sodium channel blocker clinically prescribed to people with overactive sodium channels, as well as a Nav1.8-selective agent, to evaluate the efficacy of blocking hyperactive channels on sweat production.
Variants in sodium channel genes causing functional impact on sweat glands
First, the genetic analyses demonstrated that some families with primary idiopathic hyperhidrosis contain rare coding variants in sodium channel genes, particularly SCN10A encoding Nav1.8, which was the most strongly associated one. Functionally, the Nav1.8 variants were demonstrated to have a gain-of-function impact, whereby the channel opening/activation or duration of activation was facilitated, thereby enabling unusually high excitability of the postganglionic sympathetic neurons innervating the sweat glands.
For the knocking mice, which carry the Nav1.8 mutation, the researchers found an exaggerated paw sweat that mirrored what happened to the patients. Thus, they concluded that this one gene mutation alone is responsible for the phenotype. More importantly, by administering various sodium channel inhibitors, some of which have been prescribed to patients, sweating in the mutated mice was reversed to normal, and when the drug administration was stopped, it increased again to excessive levels in a way that confirms the involvement of an overactive ion channel.
“It was interesting to have a specific case with a nerve mutation that we predicted was inhibitory, meaning it would normally shut off nerve function, yet they had hyperhidrosis,” the author added. The deeper dives uncovered another rare mutation within the water channel that controls flow within the sweat gland inhibitor, meaning, essentially, an abnormality within the structure itself to transport fluid, “suggesting the same symptom, excessive sweating, could occur either from nerve hyperfunction or from dysfunction within the sweat gland.”
Read More: The Role of in Mental Health
Author’s viewpoints
The authors argue these results show that at least a sizable subpopulation of primary hyperhidrosis represents a genuine genetically determined neurological disorder rather than a manifestation of exaggerated stress response and “nervousness.” They also argue the ability to define Nav1.8 channelopathy as a druggable mechanism indicates that therapy needs to shift from gross procedures such as endoscopic thoracic sympathectomy, in which the sympathetic chain is physically severed and may result in subsequent compensatory sweating in another part of the body, to targeted, mechanism-based interventions.
They further emphasise the biological variability of hyperhidrosis: “For some people, the underlying mechanism is centred in ion channel dysfunction in nerve cells (as with Nav1.8), while in others, it’s intrinsic to the sweat glands themselves, as we see here in the water channel mutation.” Going forward, they imagine that genetic and functional profiling will help categorise individuals and link them to the appropriate treatment, whether targeting the nerves with sodium channel blockers or cholinergic modulators, treating the glands directly, or a combination of both. Finally, the paper hints that sweating may be useful as an experimental output for examining other disorders of the autonomic system, such as postinfectious dysautonomia.
Conclusion
Taken together, the paper pins a significant proportion of primary idiopathic hyperhidrosis down to Nav1.8/SCN10. A gain-of-function mutations and demonstrates how this overly enthusiastic channel makes sympathetic nerve cells that control the sweat glands hypersensitive to a signal to sweat. The finding in mice that this overactivity could be countered by blocking the channel, coupled with the observation that one human patient with the Nav1.8 mutation produced an identical clinical picture by interfering with another sweat gland water channel, makes the phenomenon a clearly identifiable multiple-pathway problem.
The bottom line: The takeaway message is that primary hyperhidrosis isn’t “just sweating too much” because people get nervous; in fact, many see it as a very real and targetable biological problem related to nerve and sweat gland physiology that could be targeted with smart, focused therapies rather than aggressive surgery and stigma. And on the front end of psychological and quality-of-life considerations, providing clear answers about genetic and neurologic underpinnings can help patients feel seen and facilitate better, earlier management.
References +
- Neuroscience News. (2026b, July 17). Genetic cause of chronic excessive sweating discovered. Neuroscience News. https://neurosciencenews.com/hyperhidrosis-genetic-sweating-neurology-31070/
- Wohlrab, J., Bechara, F. G., Schick, C., & Naumann, M. (2023). Hyperhidrosis: A central nervous dysfunction of sweat secretion. Dermatology and Therapy, 13(2), 453–463. https://doi.org/10.1007/s13555-022-00885-w
